SX-682 Recruiting Phase 2 Trials for Pancreatic Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Recruiting | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05604560 | A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |